{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T06:29:07Z","timestamp":1762928947807,"version":"3.40.4"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","license":[{"start":{"date-parts":[[2022,3,11]],"date-time":"2022-03-11T00:00:00Z","timestamp":1646956800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Tumor lysis syndrome is a potentially lethal condition caused by rapid cell death, releasing a high level of toxic cytokines. It is common in patients with hematological malignancy but rare in solid tumors.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>A 64-year-old patient presented to our unit with a 17.3-cm hepatocellular carcinoma and marginal liver reserve. The first-stage operation of associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) was performed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnosis:<\/jats:title>\n            <jats:p>The patient was found to be anuric with grossly deranged electrolytes after the first-stage operation. Tumor lysis syndrome was diagnosed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>The patient was transferred to the intensive care unit for aggressive fluid administration and continuous venovenous hemofiltration for the management of tumor lysis syndrome.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>The patient recovered and then underwent the second-stage operation of ALPPS with extended right hepatectomy 8 days after the initial operation without any long-term sequelae.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>ALPPS is a relatively new technique in liver surgery, entailing an increased risk of tumor lysis syndrome due to an in situ tumor after the first-stage operation. Clinicians should have a high index of suspicion regarding this potentially lethal complication with prompt management.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000029040","type":"journal-article","created":{"date-parts":[[2022,4,22]],"date-time":"2022-04-22T11:02:29Z","timestamp":1650625349000},"page":"e29040","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["A case report of tumor lysis syndrome after stage-one ALPPS"],"prefix":"10.1097","volume":"101","author":[{"given":"Ho Hung","family":"Cheung","sequence":"first","affiliation":[{"name":"Department of Surgery, Queen Mary Hospital, 102 Pok Fu Lam Road, Hong Kong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2049-3140","authenticated-orcid":false,"given":"Wong Hoi","family":"She","sequence":"additional","affiliation":[{"name":"Department of Surgery, Queen Mary Hospital, 102 Pok Fu Lam Road, Hong Kong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Desmond Y.H.","family":"Yap","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Hong Kong, 102 Pok Fu Lam Road, Hong Kong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon H.Y.","family":"Tsang","sequence":"additional","affiliation":[{"name":"Department of Surgery, Queen Mary Hospital, 102 Pok Fu Lam Road, Hong Kong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tan To","family":"Cheung","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Hong Kong, 102 Pok Fu Lam Road, Hong Kong, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2022,3,11]]},"reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"03","DOI":"10.1111\/j.1365-2141.2004.05094.x","article-title":"Tumour lysis syndrome: new therapeutic strategies and classification","volume":"127","author":"Cairo","year":"2004","journal-title":"Br J Haematol"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1056\/NEJMra0904569","article-title":"The tumor lysis syndrome","volume":"364","author":"Howard","year":"2011","journal-title":"N Engl J Med"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"5389","DOI":"10.4081\/rt.2014.5389","article-title":"Tumor lysis syndrome in solid tumors: an up to date review of the literature","volume":"6","author":"Mirrakhimov","year":"2014","journal-title":"Rare Tumors"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1055\/s-2007-1007122","article-title":"Prognosis of hepatocellular carcinoma: the BCLC staging classification","volume":"19","author":"Llovet","year":"1999","journal-title":"Semin Liver Dis"},{"key":"R5-20250504","first-page":"e8355","article-title":"Tumor lysis syndrome in solid tumors: a comprehensive literature review, new insights, and novel strategies to improve outcomes","volume":"12","author":"Findakly","year":"2020","journal-title":"Cureus"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"e5606","DOI":"10.1097\/MD.0000000000005606","article-title":"The incidence and outcome of major complication following conventional TAE\/TACE for hepatocellular carcinoma","volume":"95","author":"Tu","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1111\/j.1349-7006.2008.00958.x","article-title":"Acute tumor lysis syndrome after transarterial chemoembolization for hepatocellular carcinoma","volume":"99","author":"Shiba","year":"2008","journal-title":"Cancer Sci"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"4726","DOI":"10.3748\/wjg.15.4726","article-title":"Tumor lysis syndrome after transarterial chemoembolization of hepatocellular carcinoma: case reports and literature review","volume":"15","author":"Hsieh","year":"2009","journal-title":"World J Gastroenterol"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.hemonc.2018.03.004","article-title":"Sorafenib-induced tumor lysis syndrome in a patient with metastatic hepatocellular carcinoma","volume":"13","author":"Imam","year":"2018","journal-title":"Hematol Oncol Stem Cell Ther"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"4464","DOI":"10.3748\/wjg.15.4464","article-title":"Sorafenib induced tumor lysis syndrome in an advanced hepatocellular carcinoma patient","volume":"15","author":"Huang","year":"2009","journal-title":"World J Gastroenterol"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1159\/000360362","article-title":"Spontaneous tumor lysis syndrome in a patient with metastatic hepatocellular carcinoma","volume":"23","author":"Mehrzad","year":"2014","journal-title":"Med Principles Pract"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.2214\/AJR.04.1265","article-title":"Tumor lysis syndrome after radiofrequency ablation of hepatocellular carcinoma","volume":"185","author":"Lehner","year":"2005","journal-title":"AJR Am J Roentgenol"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/SLA.0b013e318248577d","article-title":"Playing play-Doh to prevent postoperative liver failure: the \u201cALPPS\u201d approach","volume":"255","author":"de Santibanes","year":"2012","journal-title":"Ann Surg"},{"key":"R14-20250504","first-page":"210","article-title":"Oxidative stress in humans following the Pringle manoeuvre","volume":"5","author":"Garcea","year":"2006","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.clon.2006.09.005","article-title":"Tumour lysis syndrome in solid tumours","volume":"18","author":"Gemici","year":"2006","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1053\/j.ackd.2013.07.001","article-title":"Tumor lysis syndrome: new challenges and recent advances","volume":"21","author":"Wilson","year":"2014","journal-title":"Adv Chronic Kidney Dis"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000029040","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T04:01:40Z","timestamp":1746331300000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000029040"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,11]]},"references-count":16,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000029040","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"type":"print","value":"0025-7974"},{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2022,3,11]]},"assertion":[{"value":"2021-12-17","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-02-23","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}